Application of Beta-Distribution and Combined Uniform and Binomial Methods in Longitudinal Modeling of Bounded Outcome Score Data.

The AAPS Journal
Chuanpu HuAmarnath Sharma

Abstract

Disease status is often measured with bounded outcome scores (BOS) which takes a discrete set of values on a finite range. The distribution of such data is often skewed, rendering the standard analysis methods assuming normal distribution inappropriate. Among the methods used for BOS analyses, two of them have the ability to predict the data within its natural range and accommodate data skewness: (1) a recently proposed beta-distribution based approach and (2) a mixture model known as CUB (combined uniform and binomial). This manuscript compares the two approaches, using an established mechanism-based longitudinal exposure-response model to analyze data from a phase 2 clinical trial in psoriatic patients. The beta-distribution-based approach was confirmed to perform well, and CUB also showed potential. A separate issue of modeling clinical trial data is that the collected baseline disease score range may be more limited than that of post-treatment disease score due to clinical trial inclusion criteria, a fact that is typically ignored in longitudinal modeling. The effect of baseline disease status restriction should in principle be adjusted for in longitudinal modeling.

References

Dec 1, 1996·Journal of Pharmacokinetics and Biopharmaceutics·A Sharma, W J Jusko
Mar 6, 2004·Journal of Pharmacokinetics and Pharmacodynamics·Liping ZhangLewis B Sheiner
Apr 7, 2006·Biostatistics·Emmanuel LesaffreRoula Tsonaka
Feb 9, 2007·The New England Journal of Medicine·Gerald G KruegerUNKNOWN CNTO 1275 Psoriasis Study Group
Dec 7, 2007·Journal of Pharmacokinetics and Pharmacodynamics·Matthew M HutmacherKenneth G Kowalski
May 21, 2008·Journal of Clinical Pharmacology·Chuanpu Hu, Honghui Zhou
Oct 3, 2009·Genes & Development·Arndt F SiekmannNathan D Lawson
Dec 31, 2009·Pharmaceutical Statistics·Chuanpu HuHonghui Zhou
Apr 8, 2011·Statistics in Medicine·Matthew M HutmacherSujatha Menon
Jan 1, 2013·Journal of Pharmacokinetics and Pharmacodynamics·Chuanpu HuHonghui Zhou
Jul 21, 2014·Journal of Pharmacokinetics and Pharmacodynamics·Chuanpu HuHonghui Zhou
Nov 5, 2015·CPT: Pharmacometrics & Systems Pharmacology·R V OvergaardC W Tornøe
Aug 11, 2016·Statistical Methods in Medical Research·Moreno Ursino, Mauro Gasparini
Jul 22, 2017·Journal of Pharmacokinetics and Pharmacodynamics·Chuanpu HuAmarnath Sharma
May 3, 2019·CPT: Pharmacometrics & Systems Pharmacology·Robert J Bauer
Mar 19, 2020·The AAPS Journal·Chuanpu HuAmarnath Sharma

❮ Previous
Next ❯

Software Mentioned

NONMEM OFV
CUB
NONMEM

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.